openPR Logo
Press release

Pompe Disease Therapeutic Market to Exhibit Rapid Surge in Consumption in the COVID-19 Crisis

01-11-2021 02:07 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Pompe Disease Therapeutic Market to Exhibit Rapid Surge

Pompe disease or also referred to as Glycogen storage disease type II is an autosomal recessive metabolic disorder that damages nerve cells and muscles throughout the body. It is typically caused due to the accumulation of glycogen in the lysosome, owing to deficiency of the lysosomal acid alpha-glucosidase enzyme.

Rising prevalence of Pompe disease is expected to drive growth of the global Pompe disease therapeutic market during the forecast period. According to the National Organization for Rare Disorders (NORD), around 1 in 40,000 births in the U.S. and the Netherlands are affected with Pompe disease. According to the same source, a recent study showed that the state of Missouri reported a higher prevalence of 1 in 5,463. Pompe disease can occur in various populations and ethnic groups across the globe. According to the Pompe Disease News, around 5,000 to 10,000 people have Pompe diseases worldwide. As a result of this, the demand for new therapeutic treatment options is increasing globally.

Buy Now With Covid-19 Analysis and Updated Information@ https://www.coherentmarketinsights.com/insight/buy-now/1316

Thus, these factors are expected to drive growth of the global Pompe disease therapeutic market during the forecast period. Furthermore, proactive initiatives taken by government authorities to develop and manufacture innovative products for the diagnosis and treatment of rare diseases are expected to propel the global Pompe disease therapeutic market growth over the forecast period.

However, the high cost associated with treatment is expected to hinder the global Pompe disease therapeutic market growth over the forecast period. Continuous research and development activities can present lucrative growth opportunities in the global Pompe disease therapeutic market in the near future. Among regions, North America is expected to witness significant growth in the global Pompe disease therapeutic market during the forecast period. This is owing to the presence of robust healthcare infrastructure across the region. Furthermore, Europe is expected to register a robust growth rate over the forecast period, owing to continuous research and development activities combined with proactive support from government authorities to improve the healthcare sector.

For Further Report Related Query@ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1316

Key companies operating in the global Pompe disease therapeutic market are CENTOGENE AG, Amicus Therapeutics, Inc., AVROBIO, Inc., Sanofi, Valerion Therapeutics, Audentes Therapeutics, and Oxyrane.

For instance, in June 2020, Sanofi announced results of Phase III trial for its investigational enzyme replacement therapy (ERT) avalglucosidase alfa indicated for late-onset Pompe disease (LOPD) with clinically meaningful improvement.

Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pompe Disease Therapeutic Market to Exhibit Rapid Surge in Consumption in the COVID-19 Crisis here

News-ID: 2223252 • Views: 394

More Releases from Coherent Market Insights

Respiratory Air Conditioning Devices Market See Incredible Growth 2022-2028 | Be …
Coherent Market Insights has released a new research study on the "Respiratory Air Conditioning Devices Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Respiratory Air Conditioning Devices Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Respiratory Air Conditioning Devices
Liquid Biopsy Market Expected to Expand at a Steady 2022-2028 | Biocept, Inc., Q …
Coherent Market Insights has released a new research study on the "Liquid Biopsy Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Liquid Biopsy Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Liquid Biopsy Market research report is an intelligence
Extracorporeal Membrane Oxygenation System Market Future Business Opportunities …
Coherent Market Insights has released a new research study on the "Extracorporeal Membrane Oxygenation System Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Extracorporeal Membrane Oxygenation System Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Extracorporeal Membrane Oxygenation System
Radiopharmaceuticals in Nuclear Medicine Market Huge Growth in Future Scope 2022 …
Coherent Market Insights has released a new research study on the "Radiopharmaceuticals in Nuclear Medicine Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Radiopharmaceuticals in Nuclear Medicine Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Radiopharmaceuticals in Nuclear Medicine

All 5 Releases


More Releases for Pompe

Pompe Disease Drug Market Epidemiology 2030| Delveinsight
DelveInsight's Pompe Disease Market Insights, Epidemiology, and Market Forecast 2030 report delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Pompe Disease market report provides current treatment practices, emerging drugs, Pompe Disease market share of the individual therapies, current and forecasted Pompe Disease market Size
Pompe Disease Therapeutic Market - Attractive Growth Opportunities 2017 - 2025
Manufacturers are focusing on finding new solutions by expanding their pipeline to cater the demand for pompe disease therapeutics market. For instance, in September, 2017, Avrobio Inc. expanded their products pipeline with gene therapy to treat pompe disease by utilizing a proprietary lysosomal targeting sequence to deliver high levels of enzyme to lysosomes. Furthermore, in October 2017, Amicus Therapeutics received orphan drug designation to ATB200/AT2221 from the U.S. FDA for
Pompe Disease Market Intelligence with Competitive Landscape 2024
Pompe disease is a rare, progressive, autosomal recessively inherited metabolic disorder, and is often a fatal muscular disease that affects one of the lysosomal enzymes. Pompe disease can also be called as a glycogen storage disease or acid alpha-glycosidase deficiency or GAA deficiency. It mainly occurs due to accumulation of glycogen in some tissues and organs, particularly muscles, leading to abnormal functioning. The inability of breaking the lysosomal glycogen lies
Pompe Disease Market Size – Industry Share Report 2024
Pompe disease is a rare, progressive, autosomal recessively inherited metabolic disorder, and is often a fatal muscular disease that affects one of the lysosomal enzymes. Pompe disease can also be called as a glycogen storage disease or acid alpha-glycosidase deficiency or GAA deficiency. It mainly occurs due to accumulation of glycogen in some tissues and organs, particularly muscles, leading to abnormal functioning. The inability of breaking the lysosomal glycogen lies
Global Pompe Disease Industry Growth and Analysis 2016 – 2024
Pompe disease is a rare, progressive, autosomal recessively inherited metabolic disorder, and is often a fatal muscular disease that affects one of the lysosomal enzymes. Pompe disease can also be called as a glycogen storage disease or acid alpha-glycosidase deficiency or GAA deficiency. It mainly occurs due to accumulation of glycogen in some tissues and organs, particularly muscles, leading to abnormal functioning. The inability of breaking the lysosomal glycogen lies
Pompe Disease Market : Size, Status and Forecast 2016 - 2024
Pompe disease is a rare, progressive, autosomal recessively inherited metabolic disorder, and is often a fatal muscular disease that affects one of the lysosomal enzymes. Pompe disease can also be called as a glycogen storage disease or acid alpha-glycosidase deficiency or GAA deficiency. It mainly occurs due to accumulation of glycogen in some tissues and organs, particularly muscles, leading to abnormal functioning. The inability of breaking the lysosomal glycogen lies